Liminatus Pharma LIMN 深 沪
已收盘 07-02 16:00:00 美东时间
0.1425
+0.028
+24.13%
华盛通- 最 高0.207
- 今 开0.1661
- 成交量 5.25亿股
- 最 低 0.1246
- 昨 收 0.1148
- 总市值 639.51万
- 52周最高 9.38
- 市盈率 静 --
- 换手率 1169.68%
- 52周最低 0.095
- 委 比 4.60%
- 总股本 4487.76万
- 历史最高 33.66
- 量 比 24.05
- 振 幅 71.78%
- 历史最低 0.095
- 每 手 1
- 风险率 2.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多11 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma (NASDAQ:LIMN) shares rose 26.04% to $0.14. The market value of their outstanding shares is at $5.8 milli...
07-03 01:05
Liminatus Pharma Amends Proposed $320M Merger Deal With InnocsAI As Closing Now Anticipated Before Shareholder Approval On July 2
Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, today announced that it has amended and restated the previously announced definitive merger agreement with InnocsAI LLC ("InnocsAI"), an oncology biotechnology compan...
07-01 04:32
Liminatus Pharma announces annual shareholder meeting
Liminatus Pharma announces annual shareholder meeting Liminatus Pharma will hold its annual shareholder meeting in Fullerton, California in July 2026. Shareholders will vote to elect two directors: Nicholas Fernandez, Dr. Ji Yeon Baek. A proposal seeks shareholder authorization for a reverse stock s
06-30 18:05
Liminatus Pharma secures $1.9M cash via warrant exercises
Liminatus Pharma (LIMN) has entered into a warrant exercise agreement to exercise certain outstanding warrants to purchase an aggregate of 10.34M shares of common stock of the company for gross procee...
06-03 21:14
Liminatus Pharma Enters Warrant Exercise Agreement With Existing Investors To Purchase 10,344,000 Shares At $0.18 Per Share
In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders were issued new unregistered warrants to purchase an aggregate of 20,688,000 million shares of common stock (the "New
06-03 20:33
超20亿元！一细胞治疗公司被收购
（来源：细胞与基因治疗领域） 近期，美国癌症免疫治疗公司Liminatus Pharma宣布，已达成最终协议，将以3.2亿美元（约合人民币21.6亿元）收购细...
05-31 15:17
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock increased by 40.3% to $7.21 dur...
05-22 05:06
Liminatus Pharma Announces Nasdaq Delisting Notification
Liminatus Pharma, Inc. received a delisting notice from Nasdaq as it failed to meet the $50 million market value of listed securities and $15 million market value of publicly held shares requirements. The company had 180 days to regain compliance but did not meet the criteria by May 18, 2026. Trading of its securities will be suspended on May 29, 2026, unless an appeal is filed by May 27, 2026. The company intends to request an appeal to delay de...
05-22 00:28
Liminatus Pharma Enters Merger Agreement With InnocsAI On May 17, 2026; InnocsAI Members To Receive 1.6B Shares At $0.20 Per Share And 20% Contingent Value Rights
On May 17, 2026, Liminatus Pharma, Inc. (the "Company") entered into a Merger Agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with InnocsAI LLC,
05-21 05:12
Why NN Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-year guidance. Other gainers include NICM, AGAE, IMMP, LIMN, CIIT, MLSS, LAES, GBR, and STNE. Losers include SNAL, MIMI, ARAI, and SURG.
04-15 16:51
